医療者向けTOP
業 績
| ■ 2000年 | ■ 2001年 | ■ 2002年 | ■ 2003年 | ■ 2004年 | ■ 2005年 | ■ 2006年 | ■ 2007年 | ||||||||
| ■ 2008年 | ■ 2009年 | ■ 2010年 | ■ 2011年 | ■ 2012年 | ■ 2013年 | ■ 2014年 | ■ 2015年 | ||||||||
| ■ 2016年 | ■ 2017年 | ■ 2018年 | ■ 2019年 | ■ | ■ | ■ | ■ |
■ Neuro-Tokushima achievements 2013
1.論文･ 著書など (アルファベット順または五十音順)
1A 英文
1A-a. 原著
Akaike N, Shin MC, Wakita M, Torii Y, Harakawa T, Ginnaga A, Kato K, Kaji R, Kozaki S. Transynaptic inhibition of spinal transmission by A2 botulinum toxin. J Physiol 2013; 591(Pt 4): 1031-1043
PubMed Journal
Fujita K, Izumi Y, Harada M, Kaji R. Crossed cerebellar hyperperfusion without restricted diffusion in status epilepticus. J Neurol 2013; 260(2): 674-676
PubMed Journal
Fujita K, Matsui N, Takahashi Y, Iwasaki Y, Yoshida M, Yuasa T, Izumi Y, Kaji R. Increased interleukin-17 in the cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease: a case-control study of rapidly progressive dementia. J Neuroinflammation 2013; 10: 135
PubMed
Journal
Fujita K, Osaki Y, Harada M, Kono S, Miyajima H, Izumi Y, Kaji R. Brain and liver iron accumulation in aceruloplasminemia. Neurology 2013; 81(24): 2145-2146
PubMed Journal
Fujita K, Sakai W, Harada M, Sakaki M, Mure H, Nagahiro S, Izumi Y, Kaji R. Basal ganglia hyperintensity on T1-weighted imaging of a patient with central nervous system metastasis producing carcinoembryonic antigens. Intern Med 2013; 52(3): 381-383
PubMed Journal
Goto S, Kawarai T, Morigaki R, Okita S, Koizumi H, Nagahiro S, Munoz EL, Lee LV, Kaji R. Defects in the striatal neuropeptide Y system in X-linked dystonia-parkinsonism. Brain 2013; 136(Pt 5): 1555-1567
PubMed Journal
Inui T, Kawarai T, Fujita K, Kawamura K, Mitsui T, Orlacchio A, Kamada M, Abe T, Izumi Y, Kaji R. A new CSF1R mutation presenting with an extensive white matter lesion mimicking primary progressive multiple sclerosis. J Neurol Sci 2013; 334(1-2): 192-195
PubMed Journal
Izumi Y, Miyamoto R, Morino H, Yoshizawa A, Nishinaka K, Udaka F, Kameyama M, Maruyama H, Kawakami H. Cerebellar ataxia with SYNE1 mutation accompanying motor neuron disease. Neurology 2013; 80(6): 600-601
PubMed Journal
Kato K, Akaike N, Kohda T, Torii Y, Goto Y, Harakawa T, Ginnaga A, Kaji R, Kozaki S. Botulinum neurotoxin A2 reduces incidence of seizures in mouse models of temporal lobe epilepsy. Toxicon 2013; 74: 109-115
PubMed Journal
Kawarai T, Pasco PM, Teleg RA, Kamada M, Sakai W, Shimozono K, Mizuguchi M, Tabuena D, Orlacchio A, Izumi Y, Goto S, Lee LV, Kaji R. Application of long-range polymerase chain reaction in the diagnosis of X-linked dystonia-parkinsonism. Neurogenetics 2013; 14(2): 167-169
PubMed Journal
Koizumi H, Morigaki R, Okita S, Nagahiro S, Kaji R, Nakagawa M, Goto S. Response of striosomal opioid signaling to dopamine depletion in 6-hydroxydopamine-lesioned rat model of Parkinson's disease: a potential compensatory role. Front Cell Neurosci 2013; 7: 74
PubMed Journal
Maruyama H, Morino H, Izumi Y, Noda K, Kawakami H. Convenient diagnosis of spinal and bulbar muscular atrophy using a microchip electrophoresis system. Am J Neurodegener Dis 2013; 2(1): 35-39
PubMed
Mitsui T, Kuroda Y, Ueno S, Matsui N, Kaji R. FK506 attenuates thymic output in patients with myasthenia gravis. Arch Med Sci 2013; 9(6): 1090-1096
PubMed
Miyashiro A, Sugihara K, Kawarai T, Miyamoto R, Izumi Y, Morino H, Maruyama H, Orlacchio A, Kawakami H, Kaji R. Oromandibular dystonia associated with SCA36. Mov Disord 2013; 28(4): 558-559
PubMed Journal
Morigaki R, Nakataki M, Kawarai T, Lee LV, Teleg RA, Tabuena MD, Mure H, Sako W, Pasco PM, Nagahiro S, Iga J, Ohmori T, Goto S, Kaji R. Depression in X-linked dystonia-parkinsonism: a case-control study. Parkinsonism Relat Disord 2013; 19(9): 844-846
PubMed Journal
Morita N, Harada M, Satomi J, Terasawa Y, Kaji R, Nagahiro S. Frequency of emerging positive diffusion-weighted imaging in early repeat examinations at least 24 h after transient ischemic attacks. Neuroradiology 2013; 55(4): 399-403
PubMed Journal
Multiple-System Atrophy Research Collaboration. Mutations in COQ2 in familial and sporadic multiple-system atrophy. N Engl J Med 2013; 369(3): 233-244
PubMed Journal
Nakamura R, Atsuta N, Watanabe H, Hirakawa A, Watanabe H, Ito M, Senda J, Katsuno M, Tanaka F, Izumi Y, Morita M, Ogaki K, Taniguchi A, Aiba I, Mizoguchi K, Okamoto K, Hasegawa K, Aoki M, Kawata A, Abe K, Oda M, Konagaya M, Imai T, Nakagawa M, Tsuji S, Kaji R, Nakano I, Sobue G. Neck weakness is a potent prognostic factor in sporadic amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry 2013; 84(12): 1365-1371
PubMed Journal
Nakane S, Fujita K, Shibuta Y, Matsui N, Harada M, Urushihara R, Nishida Y, Izumi Y, Kaji R. Successful treatment of stiff person syndrome with sequential use of tacrolimus. J Neurol Neurosurg Psychiatry 2013; 84(10): 1177-1180
PubMed Journal
Shibuta Y, Shimatani Y, Nodera H, Izumi Y, Kaji R. Increased variability of axonal excitability in amyotrophic lateral sclerosis. Clin Neurophysiol 2013; 124(10): 2046-2053
PubMed Journal
Terasawa Y, Osaki Y, Kawarai T, Sugimoto T, Orlacchio A, Abe T, Izumi Y, Kaji R. Increasing and persistent DWI changes in a patient with hereditary diffuse leukoencephalopathy with spheroids. J Neurol Sci 2013; 335(1-2): 213-215
PubMed Journal
Yamamura Y, Morigaki R, Kasahara J, Yokoyama H, Tanabe A, Okita S, Koizumi H, Nagahiro S, Kaji R, Goto S. Dopamine signaling negatively regulates striatal phosphorylation of Cdk5 at tyrosine 15 in mice. Front Cell Neurosci 2013; 7: 12
PubMed Journal
1A-b. 総説
Kaji R. Direct central action of intramuscularly injected botulinum toxin: is it harmful or beneficial? J Physiol 2013; 591(Pt 4): 749
PubMed Journal
Kiernan MC, Kaji R. Physiology and pathophysiology of myelinated nerve fibers. Handb Clin Neurol 2013; 115: 43-53
PubMed Journal
Lehericy S, Tijssen MA, Vidailhet M, Kaji R, Meunier S. The anatomical basis of dystonia: current view using neuroimaging. Mov Disord 2013; 28(7): 944-957
PubMed Journal